SSA
DRUG

Schonfeld Strategic Advisors’s Bright Minds Biosciences DRUG Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.8M Sell
69,004
-6,597
-9% -$172K 0.01% 961
2025
Q1 		$2.72M Buy
75,601
+5,789
+8% +$208K 0.02% 706
2024
Q4 		$2.46M Buy
+69,812
New +$2.46M 0.01% 702